FDA releases new guidance for generic drug makers by Tina Reed Friday, July 20, 2018 The Trump administration continued its series of moves this week aimed at lowering prescription drug prices as it released new guidance on Friday.
FDA to form working group to examine drug importation by Paige Minemyer Thursday, July 19, 2018 As part of the Trump administration's ongoing efforts on drug prices, the FDA will convene a working group to investigate importing certain medications.
Gottlieb says biosimilars action plan will address drug costs—roundup by Tina Reed Thursday, July 19, 2018 FDA Director Scott Gottlieb announced a Biosimilars Action Plan as part of a broader plan to address drug prices, plus other healthcare headlines.
Healthcare breach costs outpace all other industries—Roundup by Evan Sweeney Monday, July 16, 2018 Data breaches cost healthcare companies $408 per record, almost twice as much as the financial industry. Plus digital health took in $4.9B this year.
Cedars-Sinai's new startup class; Ethics of innovation—Roundup by Evan Sweeney Monday, July 9, 2018 Cedars-Sinai announces nine new startups inducted into its accelerator and a study shows a 7% error rate with speech recognition software.
AHIP CEO Matt Eyles pegs drug pricing as his top priority by Evan Sweeney Thursday, July 5, 2018 New AHIP CEO Matt Eyles spent more than a decade crafting public policy for drugmakers. Now he's making drug prices his top priority.
Gottlieb: FDA needs to fill data gaps to analyze clinical trials by Paige Minemyer Monday, June 25, 2018 The Food and Drug Administration needs access to more data as it rethinks what a clinical trial looks like, said Commissioner Scott Gottlieb.
FDA faces ‘hard questions’ with Pre-Cert update by Evan Sweeney Wednesday, June 20, 2018 The FDA is making progress with its Pre-Cert program, but one attorney says "there is conflict."
Trump: 'Massive' drug price cuts coming soon—roundup by Paige Minemyer Monday, June 4, 2018 President Donald Trump has promised "massive" drug price cuts from major companies in two weeks, plus more healthcare headlines.
FDA unveils guidance to boost competition in drug markets by Paige Minemyer Thursday, May 31, 2018 The Food and Drug Administration has officially unveiled new guidance that aims to increase competition in drug markets.
